Strides Pharma Science

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue1,2021,1281,2481,3021,332
Expenses1,072998.011,0851,0531,179
EBITDA229.85226.66258.70342.80247.84
EBIT156.70169.50199.25288.86189.63
Profit Before Tax106.38122.04153.11245.47148.05
Net Profit85.62105.59131.52208.12129.28
Financial Ratios
Operating Profit Margin17.27%19.50%20.39%28.42%18.35%
Net Profit Margin8.76%9.54%11.06%17.15%10.01%
Earning Per Share (Diluted)8.9210.8113.8421.9213.77
Dividends Per Share0.000.000.000.000.00